Terms: = Lung cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun AND Staging
7 results:
1. Dual-energy computed tomography for evaluating nodal staging in lung adenocarcinoma: correlation with surgical pathology.
Huang HC; Huang YS; Chang YC; Shih JY; Chen JS; Chang YC; Wang TC
Jpn J Radiol; 2024 May; 42(5):468-475. PubMed ID: 38311704
[TBL] [Abstract] [Full Text] [Related]
2. circNFATC3 sponges miR-548I acts as a ceRNA to protect NFATC3 itself and suppressed hepatocellular carcinoma progression.
Jia C; Yao Z; Lin Z; Zhao L; Cai X; Chen S; Deng M; Zhang Q
J Cell Physiol; 2021 Feb; 236(2):1252-1269. PubMed ID: 32667692
[TBL] [Abstract] [Full Text] [Related]
3. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract] [Full Text] [Related]
4. mRNA expression and clinical significance of ERCC1, BRCA1, RRM1, TYMS and TUBB3 in postoperative patients with non-small cell lung cancer.
Han Y; Wang XB; Xiao N; Liu ZD
Asian Pac J Cancer Prev; 2013; 14(5):2987-90. PubMed ID: 23803067
[TBL] [Abstract] [Full Text] [Related]
5. [Expression and clinical significance of MAPK in non-small cell lung cancer].
Zhang ZF; Ma JQ; Zhang L
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):339-42. PubMed ID: 15854513
[TBL] [Abstract] [Full Text] [Related]
6. Small cell lung cancer: etiology, biology, clinical features, staging, and treatment.
Cook RM; Miller YE; Bunn PA
Curr Probl Cancer; 1993; 17(2):69-141. PubMed ID: 8395998
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas.
Volm M; Drings P; Wodrich W
J Cancer Res Clin Oncol; 1993; 119(9):507-10. PubMed ID: 8100821
[TBL] [Abstract] [Full Text] [Related]
